Earnings History Data for Rafael Holdings, Inc. (RFL) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Rafael Holdings, Inc.

Rafael Holdings Inc. manufactures metabolic oncology drugs to treat cancer. The company's product pipeline consists of CPI-613, CPI-618, CPI-1826 and CPI-3220 which are in clinical stages. Rafael Holdings Inc. is based in Newark, United States.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
17-03-2022	AH		RFL	Rafael Holdings, Inc.	45.60	-0.12	0.00	-0.07	Rafael Holdings GAAP EPS of -$0.12, revenue of $1.11M [3/17/2022 5:37 PM]	2.55	0.41 (19.16%)	2.14	0.0 (0.00%)	2.05 - 66.44	225,166	186,763	127
Rafael Holdings GAAP EPS of -$0.12, revenue of $1.11M [3/17/2022 5:37 PM] Rafael Holdings Reports Second Quarter Fiscal 2022 Financial Results [Mar-17-22 04:01PM]
17-03-2021	AH	After the close (Mar 17)	RFL	Rafael Holdings, Inc.	718.21	-0.07	0.00	-0.08	Rafael Holdings reports FQ2 results [3/17/2021 4:46 PM]	47.03	-0.83 (-1.73%)	0.0	0.0 (0.00%)	9.40 - 52.87	50,202	100,000	0
Rafael Holdings reports FQ2 results [3/17/2021 4:46 PM] Rafael Holdings Reports Second Quarter Fiscal Year 2021 Results [Mar-17-21 04:30PM]
29-10-2020	AH		RFL	Rafael Holdings, Inc.	267.96	-0.05	0.00	-0.16	Rafael Holdings reports Q4 results [10/29/2020 5:00 PM]	16.55	-0.92 (-5.27%)	16.72	0.0 (0.00%)	9.40 - 23.76	19,532	14,642	678